Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Pabst

Showing results (221-230 of 332) with videos related to

Pageof 34
Sort By:
British Journal of Haematology|March 29, 2016
Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08Felicitas Hitz, Emanuele Zucca, Thomas Pabst, et al.
Hemasphere|November 29, 2023
Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AMLJesse M Tettero, Yara Buisman, Lok Lam Ngai, et al.
The Journal of Infectious Diseases|August 20, 2021
Association of Host Factors With Antibody Response to Seasonal Influenza Vaccination in Allogeneic Hematopoietic Stem Cell Transplant PatientsJanina Linnik, Mohammedyaseen Syedbasha, Hans-Michael Kaltenbach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2015
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)Christoph Mamot, Dirk Klingbiel, Felicitas Hitz, et al.
Blood|September 22, 2018
Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myelomaChristoph Driessen, Rouven Müller, Urban Novak, et al.
Annals of Medicine|February 28, 2026
Can hyperleukocytosis be caused by a non-hematologic condition? A 10-year retrospective tertiary-care center cohort studyElisavet Moutzouri, Emmanuel Häfliger, Katarzyna Aleksandra Jalowiec, et al.
Hemasphere|March 21, 2024
Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort studyPhilipp Berning, Evgenii Shumilov, Markus Maulhardt, et al.
Swiss Medical Weekly|October 23, 2025
Updated recommendations for diagnosis and treatment of multiple myeloma in SwitzerlandMartina Bertschinger, Holger W Auner, Veronika Ballova, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 1, 2017
Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparisonAnnic Baumgartner, Mario Bargetzi, Annika Bargetzi, et al.
Swiss Medical Weekly|February 28, 2013
Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countriesJakob R Passweg, Helen Baldomero, Mario Bargetzi, et al.
Pageof 34

Showing results (221-230 of 332) with videos related to

Sort By:
Pageof 34
British Journal of Haematology|March 29, 2016
Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08Felicitas Hitz, Emanuele Zucca, Thomas Pabst, et al.
Hemasphere|November 29, 2023
Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AMLJesse M Tettero, Yara Buisman, Lok Lam Ngai, et al.
The Journal of Infectious Diseases|August 20, 2021
Association of Host Factors With Antibody Response to Seasonal Influenza Vaccination in Allogeneic Hematopoietic Stem Cell Transplant PatientsJanina Linnik, Mohammedyaseen Syedbasha, Hans-Michael Kaltenbach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2015
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)Christoph Mamot, Dirk Klingbiel, Felicitas Hitz, et al.
Blood|September 22, 2018
Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myelomaChristoph Driessen, Rouven Müller, Urban Novak, et al.
Annals of Medicine|February 28, 2026
Can hyperleukocytosis be caused by a non-hematologic condition? A 10-year retrospective tertiary-care center cohort studyElisavet Moutzouri, Emmanuel Häfliger, Katarzyna Aleksandra Jalowiec, et al.
Hemasphere|March 21, 2024
Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort studyPhilipp Berning, Evgenii Shumilov, Markus Maulhardt, et al.
Swiss Medical Weekly|October 23, 2025
Updated recommendations for diagnosis and treatment of multiple myeloma in SwitzerlandMartina Bertschinger, Holger W Auner, Veronika Ballova, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 1, 2017
Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparisonAnnic Baumgartner, Mario Bargetzi, Annika Bargetzi, et al.
Swiss Medical Weekly|February 28, 2013
Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countriesJakob R Passweg, Helen Baldomero, Mario Bargetzi, et al.
Pageof 34